Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$71,129
-$7,336 QoQ
Shares Held
563
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#2,030
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Glen Eagle Advisors, LLC holds $41,817,560 across 12 Drug Manufacturers - General names. GILD ranks #10 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
113,724 | $28,882,484 | |
| 2 | ABBV |
AbbVie Inc.
|
21,140 | $5,319,669 | |
| 3 | LLY |
ELI LILLY & Co
|
3,599 | $4,316,748 | |
| 4 | MRK |
Merck & Co., Inc.
|
8,886 | $1,141,851 | |
| 5 | PFE |
Pfizer Inc
|
30,849 | $742,843 | |
| 6 | AMGN |
Amgen Inc
|
1,750 | $633,710 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,641 | $267,414 | |
| 8 | GSK |
GSK plc
|
4,548 | $238,406 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $71,129 | 563 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $78,465 | 563 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $57,565 | 469 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $47,508 | 428 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $42,684 | 385 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $43,139 | 385 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $35,562 | 385 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $32,278 | 385 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $38,352 | 559 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $45,415 | 620 | Shares | Sole | 2024-07-03 | |
| 2023-12-31 | $57,436 | 709 | Shares | Sole | 2024-08-13 | |
| 2023-09-30 | $52,982 | 707 | Shares | Sole | 2024-08-13 | |
| 2023-06-30 | $54,488 | 707 | Shares | Sole | 2024-08-13 | |
| 2023-03-31 | $63,886 | 770 | Shares | Sole | 2024-08-13 | |
| 2022-12-31 | $74,947 | 873 | Shares | Sole | 2024-08-13 | |
| 2022-09-30 | $53,793 | 872 | Shares | Sole | 2024-08-13 | |
| 2022-06-30 | $53,836 | 871 | Shares | Sole | 2024-08-13 | |
| 2022-03-31 | $54,931 | 924 | Shares | Sole | 2024-08-13 | |
| 2021-12-31 | $66,946 | 922 | Shares | Sole | 2024-08-13 | |
| 2021-09-30 | $212,763 | 3,046 | Shares | Sole | 2024-08-13 | |
| 2021-06-30 | $216,013 | 3,137 | Shares | Sole | 2024-08-13 | |
| 2021-03-31 | $196,539 | 3,041 | Shares | Sole | 2024-08-13 | |
| 2020-12-31 | $196,394 | 3,371 | Shares | Sole | 2024-08-13 | |
| 2020-09-30 | $241,512 | 3,822 | Shares | Sole | 2024-08-13 | |
| 2020-06-30 | $292,833 | 3,806 | Shares | Sole | 2024-08-13 | |
| 2020-03-31 | $223,831 | 2,994 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||